Cox analysis indicated that ADE, older age, male gender, previous non-use of cotrimoxazole, advanced WHO clinical stage, and low baseline CD4+ cell count were the risk factors for death. This evidence concerns the gene CD4 and acute disseminated encephalomyelitis.